PRPaul R. Roberts

Paul R. Roberts

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paul R. Roberts has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Darren Green

    Salford Care Organisation, Northern Care Alliance NHS Foundation Trust, UK; University of Manchester, Manchester, UK

    2 shared publications
  • Darren Green

    Salford Royal NHS Foundation Trust, Salford, UK

    1 shared publication
  • Gruschen R Veldtman

    From Wessex Cardiothoracic Centre, Southampton University Hospital, Southampton, United Kingdom

    1 shared publication
  • Shankar N. Sadagopan

    Wessex Cardiothoracic Centre, Southampton University Hospital, Southampton, United Kingdom

    1 shared publication

Latest Publications

  • Republished article: Arrhythmias in chronic kidney disease

    by Paul R Roberts, Darren Green

    Chronic kidney disease (CKD) is defined as evidence of kidney damage or a glomerular filtration rate (GFR) ≤60 ml/min/1.73 m2 (table 1). The most common causes of CKD are hypertension and diabetes mellitus. The many causes of CKD are associated with different varying prognoses. Patients with adult polycystic kidney disease have a 50% lifetime risk of needing dialysis compared with 25% for type 1 diabetes and <5% for type 2 diabetes. Dialysis is usually considered when GFR falls below 10 ml/min/1.73 m2 but the exact timing will often be dictated by clinical circumstances. This may be refractory oedema, hyperkalaemia and acidosis, uraemia or unacceptable symptoms. Dialysis only partially replaces the excretory function of the kidneys and so the morbidity and mortality associated with CKD are not completely resolved with dialysis. In fact, mortality in the dialysis patient is very high. The life expectancy of a 25-year-old dialysis patient is 12 years, compared with 32 years for an age equivalent transplant recipient and 52 years for a 25-year-old in the general population.1 Even patients with CKD stage 5 will only have a 20–25% chance of surviving long enough to require dialysis. The greatest cause of death in CKD is premature cardiovascular disease. For example, fewer than one in five patients with heart failure will have a normal GFR and 38% of the prevalent dialysis population have coronary artery disease (CAD) (17% previous myocardial infarction, 23% symptoms of angina).2 Both cardiac and renal systems appear to be completely interdependent, further emphasising the concept of the ‘cardiorenal syndrome’. This is highlighted when considering arrhythmias in patients with impaired renal function. View this table: Table 1 Stages of chronic kidney disease The arrhythmia burden of the patient with CKD is high, with the single greatest contributor to mortality in end stage renal disease (ESRD) being sudden cardiac death (SCD). SCD accounts for …


  • Arrhythmias in chronic kidney disease

    by Paul R Roberts, Darren Green


  • VENTRICULAR ARRHYTHMIAS AND SUDDEN DEATH IN PATIENTS WITH CHRONIC KIDNEY DISEASE

    by Darren Green, Paul R. Roberts

    One in four dialysis patients will die suddenly. Most do not fall into the high-risk categories that are associated with sudden death in the general population. The cause of sudden death in the dialysis population is unknown. It may be related to factors associated with chronic kidney disease (CKD) itself, for example, inflammation, vascular stiffness, left ventricular hypertrophy, coronary artery disease, electrolyte/fluid abnormalities or autonomic dysfunction. Studies of patients with implantable cardioverter defibrillators have shown that patients with CKD are more likely to use their devices for ventricular arrhythmias but in spite of this still have a high associated mortality. Until a comprehensive risk stratification strategy is understood, minimising risk by good control of basic parameters such as fluid balance, electrolytes and blood pressure, along with careful assessment of all patients for evidence of coronary artery disease and heart failure is the mainstay of management of the CKD patient.


  • Extraction of Chronic Pacing Lead and Angioplasty for Complete Superior Baffle Obstruction in Complex Congenital Heart Disease

    by Shankar N. Sadagopan, Gruschen R Veldtman, Paul R. Roberts

    Laser lead extraction in adult patients with congenital heart disease is safe and effective. Baffle angioplasty for obstruction in patients with a Mustard procedure is well established. We describe a unique combined interventional and electrophysiological approach on a patient with superior baffle obstruction. This technique utilized the channel created after extracting the chronic pacing lead to cross the obstruction and stent angioplasty of the superior baffle.


  • Open Access

    Follow up and optimisation of cardiac pacing

    by Paul R Roberts

    In order to follow up patients with implanted devices adequately there has to be a basic resource provision in terms of real estate, equipment, and appropriately trained personnel. A dedicated area for pacemaker follow up should be provided which enables the patient to have their appointment performed in privacy and safety. Full resuscitation facilities should be immediately available, though recourse to resuscitation facilities as a direct consequence of a pacemaker follow up is extremely rare. Relevant pacemaker programmers and appropriate technical information for all followed pacemakers should be available. A comprehensive list of basic required equipment is described in table 2. Pacemaker follow up is increasingly performed by non-medical staff such as cardiac physiologists (technicians) and nursing staff. The facility should exist in these circumstances for the patients to have access to medical input in the event of an emergency or problematic follow up. There should be a basic competency level of those staff performing follow up. This level is often defined at a national level but should certainly be defined locally.